Filter
104
Text search:
Moderna
vaccine
Featured
Recommendations
14
Language
Document type
Fact sheets
30
Studies & Reports
27
Guidelines
22
Manuals
6
Resource Platforms
5
Training Material
4
Online Courses
3
Infographics
2
Strategic & Response Plan
2
No document type
2
Videos
1
Countries / Regions
Germany
9
Ukraine
5
Argentina
4
Middle East and North Africa
4
Paraguay
4
China
3
Brazil
3
Russia
3
Global
3
Colombia
2
Ecuador
2
Latin America and the Carribbean
2
Guinea-Bissau
1
Ghana
1
Haiti
1
Philippines
1
Kenya
1
South Africa
1
Mozambique
1
Angola
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
Africa
1
Eastern Europe
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
43
Clinical Guidelines
3
Key Resources
3
Annual Report MEDBOX
1
Public Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
89
Refugee
3
Conflict
2
Health Financing Toolbox
2
Rapid Response
1
TB
1
Pharmacy
1
This presentation presents the issues we confront in deciding how to communicate to the public that COVID-19 vaccine recommendations reflect the state of scientific knowledge.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in
...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage exist
...
first issued 18 August 2022
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br
...
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is importa
...
Child and adolescent vaccine safety report
This report on the safety of COVID-19 vaccination in children and adolescents in Argentina includes data from the start of the adolescent campaign
in Argentina, includes data reported since the start of t
...
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
Vaccinator's Manual. CONVIDECIA Vaccine
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given
...